cartouche ECN WORKSHOP
-

Abstracts

Oral communications

1

2025 - Oral communication

Hyperuricemia and gout - treatment

Exploring Quality of Life Outcomes in Gout in Patients on a Treat-to-Target (TTT) Regime

Rowan Hart BMedSci (1), Amrey Krause PhD (2), Debbie Alexander BSc (1), Barbara Hauser PhD (1), Barbara Kuske PhD (1), Philip L Riches PhD (1)

2

2025 - Oral communication

Hyperuricemia and gout - treatment

Defining colchicine in-vitro effect on MSU crystals stimulated peripheral blood mononuclear cells.

Laura M. Merlo Pich (1), Calin D. Popa (2,3), Leo A.B. Joosten 1,4), Mihai G. Netea (1,5)

3

2025 - Oral communication

Hyperuricemia and gout - treatment

Cost-effectiveness of nurse-led home monitoring of serum uric acid values for gout patients in secondary care: a modelling study

Jeffrey Van Der Ven, Msc; Marcel Flendrie, Md, Phd; Fenne Van Dijck; Maike Wientjes, Msc; Noortje Van Herwaarden, Md, Phd; Philip L Riches, Md, Phd; Bart J.f. Van Den Bemt, Prof., Phd; Lise M. Verhoef, Phd

4

2025 - Oral communication

Hyperuricemia and gout - treatment

The Young, the Metabolic and the Hypertensive. A cluster analysis of gout patients and its comorbidities.

Maria Antonia Pou, Carlen Reyes, Daniel Martinez-Laguna, Pau Satorra, Cristian Tebe, Nicola Dalbeth, Cesar Diaz-Torne

5

2025 - Oral communication

Hyperuricemia and gout - treatment

Safety and Efficacy of Monthly Dosing of Pegloticase (Every 4 Weeks) With Methotrexate Co-administration in Patients with Uncontrolled Gout: Phase 4 FORWARD Open-label Trial

Orrin Troum (1), John K. Botson (2), Fang Fang (3), Katie Obermeyer (3), Afroz S. Mohammad (3), Supra Verma (3), Brian Lamoreaux 3)

6

2024 - Oral communication

Hyperuricemia and gout - treatment

“Gout remission” after 1-year of intensive urate-lowering with pegloticase

Yael Klionsky (1), Karina D Torralba (2), Katie Obermeyer (3), Lissa Padnick-Silver (3), Brian LaMoreaux (3), Gordon Lam (4)

8

2024 - Oral communication

Hyperuricemia and gout - treatment

Assessment of the inflammatory profile expressed in asymptomatic hyperuricemia with sonographic deposits, including a comparison with normouricemia and gout

Peral-Garrido, María-Luisa (1,4); Gómez-Sabater, Silvia (2,3); Caño, Rocío (2,3); Bermúdez-García, Alejandra (2,3) , Boix, Paula (4,5), Lozano, Teresa (3,6); Sánchez-Ortiga, Ruth (3,7); Perdiguero, Miguel (3,8); Caro-Martínez, Elena (9; Ruiz-García, Carolina (10); Francés, Rubén (3,4,5); Pascual, Eliseo (3,4); Andrés, Mariano (2,3,4).

Posters

9

2025 - Poster

Hyperuricemia and gout - treatment

Comorbidity burden and health resource utilization in controlled vs. uncontrolled gout: A retrospective claims-based analysis

Richard Lai (1), Suneet Grewal (2), Kaiding Zhu (3), Stephani Gray (3), Andrea Meyers (3), Brian Lamoreaux (3)

10

2025 - Poster

Hyperuricemia and gout - treatment

Colchicine efficacy and safety in crystal-induced arthritis flare in patients with severe chronic kidney disease

Lecrosnier Aude (1), Barat Eric Pharm. D (2), Ottaviani Sébastien Md (3), Rat Anne-Christine Md, Phd (4), Grosjean Julien Phd (5,6), Weber Anne-Joëlle Md (7), Guerrot Dominique Md, Phd (8), Lequerré Thierry Md, Phd(1), Vittecoq Olivier Md, Phd (1), Gérard Baptiste Md (1,9*)

11

2025 - Poster

Hyperuricemia and gout - treatment

Learning from GoutSMART: predicting time to cessation of gout flares

Rowan Hart BMedSci (1), Amrey Krause PhD (2), Debbie Alexander BSc (1), Barbara Hauser PhD (1), Barbara Kuske PhD (1), Philip L Riches PhD (1)

12

2025 - Poster

Hyperuricemia and gout - treatment

Gout characteristics, comorbidities and management in a long primary care database from Catalonia: the GotAP study.

Maria Antonia Pou, Carlen Reyes, Daniel Martinez-Laguna, Pau Satorra, Cristian Tebe, Nicola Dalbeth, Cesar Diaz-Torne

13

2025 - Poster

Hyperuricemia and gout - treatment

Identification of non-coding RNAs controlling gout-relevant genes

Nils Asmann (1), Nicholas A. Sumpter (1), Brenda Kischkel (1), Ezio T. Fok (2,3), Mumin Ozturk (2,3), Riku Takei (4), Megan P. Leask (6), Musa M. Mhlanga (2,3), Tony R. Merriman (4,5), Leo A. B. Joosten (1,7)

15

2024 - Poster

Hyperuricemia and gout - treatment

The response of ultrasound and clinical features of gout in patients managed with a treat-to-target serum urate protocol

David Bursill (1,2), Anita Lee1,2, Kim Griggs (1,2), Phoebe Hunter (1,2), Emma Hocking (1,2), Leah McWilliams (1), Vidya Limaye (1,2), Susanna Proudman (1,2)

16

2024 - Poster

Hyperuricemia and gout - treatment

Urate solubility in peripheral joints: Why 6.8?

Nicholas A Sumpter (1,2), Riku Takei (1), Mariana Urquiaga (1), Angelo Gaffo (1), Tony R. Merriman (1,3)

17

2024 - Poster

Hyperuricemia and gout - treatment

A Lower Frequency of ST-Elevation Myocardial Infarction in Patients with Gout

Panagiota Drivelegka, Lennart Jacobsson, Tatiana Zverkova-Sandström, Mats Dehlin

18

2024 - Poster

Hyperuricemia and gout - treatment

"Gout was the boss": a qualitative interview study of impact of gout in work.

Cesar Diaz-Torne, Maria A. Pou, Chiara Gasteiger, Anne Horne, Nicola Dalbeth

19

2024 - Poster

Hyperuricemia and gout - treatment

Rasburicase and methotrexate co-therapy in a case of difficult-to-treat gout

MF Pino-Zambrano, P Cardoso-Penafiel, CM Gomez-Gonzalez, E. Calvo-Aranda

20

2024 - Poster

Hyperuricemia and gout - treatment

Urinary oxypurinol as adherence to allopurinol compliance

Blanka Stiburkova (1,2), Lenka Hasikova (1), Josef Bartl (2)